Literature DB >> 17156142

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Raj Vuppalanchi1, Suthat Liangpunsakul, Naga Chalasani.   

Abstract

BACKGROUND AND AIM: The epidemiology of acute drug-induced liver injury (DILI) in the United States has not been well studied. We conducted a study of adults with new-onset jaundice at a nonreferral community hospital to better understand the epidemiology of acute DILI.
METHODS: This is a retrospective study of adult outpatients and inpatients (> or =18 yr) with new-onset jaundice over a 5-yr period (1999-2003) at Wishard Memorial Hospital, Indiana. Patients with new-onset jaundice were identified using our electronic medical record system and individual medical records were reviewed to extract the required clinical data. New-onset jaundice was defined as the presence of total serum bilirubin >3 mg/dL in patients without a prior total bilirubin >3 mg/dL.
RESULTS: A total of 732 eligible adults constituted our study cohort. Sepsis or altered hemodynamic state resulting in presumed ischemic liver injury is the single most common cause of jaundice (22%). Acute liver disease as a result of nonalcoholic etiologies caused new-onset jaundice in 97 patients (13%), with acute viral hepatitis in 66 patients (9%) and DILI in 29 patients (4%). Most cases of DILI were as a result of acetaminophen toxicity with idiosyncratic DILI occurring in only five patients (0.7%). No mortality was observed at 6 wk in patients who developed idiosyncratic DILI.
CONCLUSION: Idiosyncratic DILI appears to be a rare cause of new-onset jaundice in a community hospital setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17156142     DOI: 10.1111/j.1572-0241.2006.01019.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  32 in total

1.  Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

Authors:  Robert J Fontana; Paul H Hayashi; Jiezhun Gu; K Rajender Reddy; Huiman Barnhart; Paul B Watkins; Jose Serrano; William M Lee; Naga Chalasani; Andrew Stolz; Timothy Davern; Jayant A Talwakar
Journal:  Gastroenterology       Date:  2014-03-27       Impact factor: 22.682

2.  Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury.

Authors:  Ankur Jain; Pankaj Malhotra; Vikas Suri; Subhash Varma; Ashim Das; Suvradeep Mitra
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-01       Impact factor: 0.900

Review 3.  An Update on Drug-induced Liver Injury.

Authors:  Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 4.  Risk factors for idiosyncratic drug-induced liver injury.

Authors:  Naga Chalasani; Einar Björnsson
Journal:  Gastroenterology       Date:  2010-04-12       Impact factor: 22.682

Review 5.  Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Authors:  Robert J Fontana
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

6.  Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.

Authors:  Robert J Fontana; Leonard B Seeff; Raúl J Andrade; Einar Björnsson; Christopher P Day; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

7.  Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.

Authors:  J Jiang; X Zhang; R Huo; X Li; Y Yang; Z Gai; M Xu; L Shen; L Cai; C Wan; B Li; L He; S Qin
Journal:  Pharmacogenomics J       Date:  2014-12-02       Impact factor: 3.550

8.  The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.

Authors:  Maricruz Vega; Manisha Verma; David Beswick; Stephanie Bey; Jared Hossack; Nathan Merriman; Ashish Shah; Victor Navarro
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

Review 9.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 10.  Epidemiology of idiosyncratic drug-induced liver injury.

Authors:  Lauren N Bell; Naga Chalasani
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.